Study Details

Back
Study ID ACNKTxCon
Study Title A randomized, open-label, multi-center clinical trial to compare efficacy and safety of cyclosporine-based and switching cyclosporine to tacrolimus of two forms-based immunosuppressive therapy in renal transplant (KTx) recipients.
Clinicaltrials.gov Identifier NCT02268201
Compound Name FK506 / tacrolimus
Medical Indication or Disease Prevention of rejection after organ transplant
Study Sponsor Astellas Pharma China, Inc.
Collaborator Not Applicable
Study Start Date 23-Jul-2013
Study Completion Date 31-Mar-2015
Clinical Study Result
Select the language
English
Plain Language Summary
Select the language
English

QUICK SEARCH

USEFUL LINKS